Syneos Well being (NASDAQ:SYNH – Get Score) had its worth goal reduce by Citigroup from $80.00 to $70.00 in a analysis report issued on Wednesday, The Fly reviews. Citigroup’s worth goal would point out a possible upside of two.26% from the corporate’s earlier shut.
Different equities analysts have additionally just lately issued reviews concerning the inventory. Guggenheim started protection on shares of Syneos Well being in a analysis be aware on Monday, Could twenty third. They set a “purchase” score and a $81.00 goal worth for the corporate. Barclays reduce their goal worth on shares of Syneos Well being from $95.00 to $90.00 and set an “chubby” score for the corporate in a analysis be aware on Wednesday, July thirteenth. TheStreet reduce shares of Syneos Well being from a “b” score to a “c+” score in a analysis be aware on Wednesday, Could 18th. Jefferies Monetary Group reduce shares of Syneos Well being from a “purchase” score to a “maintain” score and reduce their goal worth for the corporate from $101.00 to $75.00 in a analysis be aware on Monday, April twenty fifth. Lastly, Mizuho reaffirmed a “purchase” score and set a $94.00 goal worth on shares of Syneos Well being in a analysis be aware on Friday, Could twentieth. 4 analysts have rated the inventory with a maintain score and 7 have assigned a purchase score to the corporate. In keeping with MarketBeat, Syneos Well being has a consensus score of “Reasonable Purchase” and a consensus worth goal of $87.67.
Syneos Well being Inventory Efficiency
Shares of NASDAQ SYNH opened at $68.45 on Wednesday. The agency has a fifty day transferring common worth of $71.69 and a 200-day transferring common worth of $76.74. The corporate has a debt-to-equity ratio of 0.86, a present ratio of 1.10 and a fast ratio of 1.09. The inventory has a market cap of $7.02 billion, a PE ratio of 25.73 and a beta of 1.68. Syneos Well being has a 1 yr low of $62.28 and a 1 yr excessive of $104.18.
Syneos Well being (NASDAQ:SYNH – Get Score) final introduced its quarterly earnings knowledge on Tuesday, August 2nd. The corporate reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.17. The agency had income of $1.36 billion in the course of the quarter, in comparison with analysts’ expectations of $1.39 billion. Syneos Well being had a internet margin of 5.13% and a return on fairness of 14.04%. The corporate’s income for the quarter was up 6.0% in comparison with the identical quarter final yr. Throughout the identical interval within the prior yr, the corporate posted $0.86 earnings per share. Equities analysts anticipate that Syneos Well being will publish 4.63 earnings per share for the present fiscal yr.
Insider Shopping for and Promoting at Syneos Well being
In different Syneos Well being information, Basic Counsel Jonathan Olefson offered 2,215 shares of the inventory in a transaction on Wednesday, July twentieth. The shares had been offered at a median worth of $75.00, for a complete transaction of $166,125.00. Following the completion of the transaction, the final counsel now owns 25,292 shares within the firm, valued at $1,896,900. The transaction was disclosed in a doc filed with the Securities & Trade Fee, which is out there by way of the SEC web site. In different information, CEO Michelle Keefe offered 8,333 shares of the agency’s inventory in a transaction dated Monday, July 18th. The shares had been offered at a median worth of $72.81, for a complete worth of $606,725.73. Following the completion of the sale, the chief government officer now owns 71,266 shares within the firm, valued at roughly $5,188,877.46. The transaction was disclosed in a doc filed with the Securities & Trade Fee, which is out there by way of this hyperlink. Additionally, Basic Counsel Jonathan Olefson offered 2,215 shares of the agency’s inventory in a transaction dated Wednesday, July twentieth. The inventory was offered at a median worth of $75.00, for a complete transaction of $166,125.00. Following the completion of the sale, the final counsel now owns 25,292 shares of the corporate’s inventory, valued at roughly $1,896,900. The disclosure for this sale might be discovered right here. Insiders offered 22,403 shares of firm inventory value $1,646,313 during the last 90 days. 0.34% of the inventory is owned by insiders.
Institutional Inflows and Outflows
Institutional buyers have just lately added to or decreased their stakes within the inventory. Jackson Grant Funding Advisers Inc. bought a brand new place in Syneos Well being within the 1st quarter value about $26,000. Independence Financial institution of Kentucky bought a brand new place in Syneos Well being within the 1st quarter value about $28,000. CWM LLC elevated its stake in Syneos Well being by 124.7% within the 2nd quarter. CWM LLC now owns 418 shares of the corporate’s inventory value $30,000 after shopping for an extra 232 shares in the course of the interval. First Horizon Advisors Inc. elevated its place in Syneos Well being by 306.6% in the course of the 2nd quarter. First Horizon Advisors Inc. now owns 496 shares of the corporate’s inventory valued at $35,000 after buying an extra 374 shares in the course of the interval. Lastly, CENTRAL TRUST Co bought a brand new place in Syneos Well being in the course of the 1st quarter valued at about $44,000. Hedge funds and different institutional buyers personal 98.38% of the corporate’s inventory.
About Syneos Well being
Syneos Well being, Inc gives biopharmaceutical outsourcing options firm in North America, Europe, the Center East, Africa, the Asia-Pacific, and Latin America. It operates by way of two segments, Medical Options and Business Options. The Medical Options phase provides providers for the event of diagnostics, medicine, biologics, units, and digital therapeutics within the Part I to IV of medical improvement.
Need Extra Nice Investing Concepts?
Obtain Information & Scores for Syneos Well being Each day – Enter your e-mail deal with beneath to obtain a concise day by day abstract of the most recent information and analysts’ scores for Syneos Well being and associated corporations with MarketBeat.com’s FREE day by day e-mail e-newsletter.